Question 1

Does &Partners own TXG stock?

Accepted Answer

Yes. As of its Q2 2026 13F, &Partners holds 7,172 shares of TXG (10x Genomics), worth $274,974.

Question 2

How many shares of TXG does &Partners own?

Accepted Answer

As of its Q2 2026 13F, &Partners holds 7,172 shares of TXG (10x Genomics).

Question 3

What is &Partners' TXG position worth?

Accepted Answer

As of its Q2 2026 13F, &Partners' TXG position is worth $274,974.

Question 4

Is &Partners buying or selling TXG?

Accepted Answer

In Q2 2026, &Partners reduced its TXG position by 6,448 shares (-47.3%).

Question 5

When did &Partners first buy TXG?

Accepted Answer

&Partners first reported TXG in its Q4 2025 13F and has listed it in 3 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	7,172	-47.3%	$274,974	0.0%	$38.34	0
2026-Q1	Increased	13,620	+2.1%	$289,153	0.0%	$21.23	24
2025-Q4	New	13,339	—	$217,559	0.0%	$16.31	32